Policy statement - Children as hematopoietic stem cell donors

Pediatrics

Volumn 125, Issue 2, 2010, Pages 392-404

  Diekema, Douglas S ^e   Fallat, Mary ^e   Matheny Antommaria, Armand H ^e   Holzman, Ian R ^e   Katz, Aviva L ^e   Leuthner, Steven R ^e   Ross, Lainie Friedman ^e   Webb, Sally A ^e   Baese, Philip L ^a   Levetown, Marcia ^b   Lyerly, Anne D ^c   Tsai, Ellen ^d   Berg, Jessica W ^e   Baker, Alison ^e  

^a American Academy of Child and Adolescent Psychiatry   (United States)

^b AMERICAN BOARD OF PEDIATRICS   (United States)

^c AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

^d CANADIAN PAEDIATRIC SOCIETY   (Canada)

^e NONE

Author keywords

Adolescent; Child; Cord blood transplants; Hematopoietic stem cell transplantation; Psychosocial risks; Siblings; Stem cell donors

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; BONE INJURY; BONE MARROW DEPRESSION; ETHICS; FATIGUE; FOLLOW UP; HEADACHE; HEALTH CARE POLICY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HUMAN; IMMUNE DEFICIENCY; LOW BACK PAIN; METABOLIC DISORDER; NAUSEA; NERVE INJURY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SEVERE COMBINED IMMUNODEFICIENCY; SIBLING; SLEEP DISORDER; SOCIAL PSYCHOLOGY; TISSUE INJURY; WALKING DIFFICULTY; WISKOTT ALDRICH SYNDROME; ADULT; ARTICLE; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR; INFERTILITY THERAPY; LEGAL ASPECT; METHODOLOGY; PARENT; PEDIATRICS; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; STANDARD; UNITED STATES;

ADULT; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PARENTS; PEDIATRICS; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK ASSESSMENT; SIBLINGS; TISSUE DONORS; UNITED STATES;

EID: 76049086709     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-3078     Document Type: Review

References (110)

1. Hongeng S, Krance RA, Bowman LC, et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet. 1997;350(9080):767-771
2. Gustafsson A, Remberger M, Winiarski J, Ringden O. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting. Bone Marrow Transplant. 2000;25(10): 1059-1065
3. Weisdorf DJ, Anasetti C, Antin JH, et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood. 2002;99(6):1971-1977
4. National Marrow Donor Program. Who we are: about the National Marrow Donor Program. Available at: www.marrow.org/ ABOUT/Who-We-Are/index.html. Accessed November 20, 2009
5. Beatty PG, Mori M, Milford E. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. Transplantation. 1995;60(8):778-783
6. Atlas LD. The National Marrow Donor Program in 2006: constants and challenges. Transfusion. 2006;46(7):1080-1084
7. Dew A, Collins D, Artz A, et al. Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options. Biol Blood Marrow Transplant. 2008;14(8): 938-941
8. Mathe G, Amiel JL, Schwarzenberg L, Cattan A, Schneider M. Haematopoietic chimera in man after allogeneic (homologous) bone-marrow transplantation. (Control of the secondary syndrome: specific tolerance due to the chimerism). BMJ. 1963;2(5373):1633-1635
9. Buckley RH, Lucas ZJ, Hattler BG Jr, Zmijewski CM, Amos DB. Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow. Clin Exp Immunol. 1968;3(2): 153-169
10. Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet. 1968;2(7583):1364-1366
11. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological de-ficiency. Lancet. 1968;2(7583):1366-1369
12. Gianni AM, Siena S, Bregni M, et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet. 1989;2(8663):580-585
13. Spitzer TR. Allogeneic peripheral blood stem cell transplantation. J Infus Chemother. 1996;6(1):33-38
14. Serody JS, Sparks SD, Lin Y, et al. Comparison of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant. 2000;6(4A): 434-440
15. Isola LM, Scigliano E, Skerrett D, et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant. 1997;20(12):1033-1037
16. Elfenbein GJ. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose? Pediatr Transplant. 2005;9(suppl 7):37-47
17. Grupp SA, Frangoul H, Wall D, Pulsipher MA, Levine JE, Schultz KR. Use of G-CSF in matched sibling donor pediatric allogeneic transplantation: a consensus statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee. Pediatr Blood Cancer. 2006;46(4): 414-421
18. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLAidentical sibling. N Engl J Med. 1989; 321(17):1174-1178
19. Reed W, Walters M, Lubin BH. Collection of sibling donor cord blood for children with thalassemia. J Pediatr Hematol Oncol. 2000;22(6):602-604
20. Children's Hospital Oakland Research Institute. Sibling donor cord blood program. Available at: www.chori.org/Services/ Sibling-Donor-Cord-Blood-Program/ indexcord.html. Accessed November 20, 2009
21. Associated Press. Baby is conceived to save daughter. The New York Times. February 17, 1990;1-10
22. Stewart SA. Toddler may be sister's lifesaver. USA Today. June 4, 1991;3A
23. Grewal SS, Kahn JP, MacMillan ML, Ramsay NK, Wagner JE. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotypeidentical sibling selected using preimplantation genetic diagnosis. Blood. 2004; 103(3):1147-1151
24. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996; 335(3):157-166
25. Bone Marrow Donors Worldwide. Cord blood registries. Available at: www.bmdw. org/index.php?id=statistics-cordblood. Accessed November 20, 2009
26. Kurtzberg J, Lyerly AD, Sugarman J. Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. J Clin Invest. 2005; 115(10):2592-2597
27. Fisk NM, Roberts IA, Markwald R, Mironov V. Can routine commercial cord blood banking be scientifically and ethically justified? PLoS Med. 2005;2(2):e44
28. Hayani A, Lampeter E, Viswanatha D, Morgan D, Salvi SN. First report of autologous cord blood transplantation in the treatment of a child with leukemia. Pediatrics. 2007;119(1). Available at: www.pediatrics. org/cgi/content/full/119/1/e296
29. American Academy of Pediatrics, Section on Hematology/Oncology and Section on Allergy and Immunology. Cord blood banking for potential future transplantation. Pediatrics. 2007;119(1):165-170
30. American Medical Association, Council on Ethical and Judicial Affairs. Umbilical Cord Blood Banking. Chicago, IL: American Medical Association; 2007. CEJA report 9-I-07. Available at: www.ama-assn.org/ama1/ pub/upload/mm/369/ceja-9i07.pdf. Accessed November 20, 2009
31. American College of Obstetrics and Gynecology, Committee on Obstetric Practice and Committee on Genetics. Routine storage of umbilical cord blood for potential future transplantation: committee opinion No. 183. Int J Gynaecol Obstet. 1997;58(2): 257-259
32. Ballen KK, Barker JN, Stewart SK, Greene MF, Lane TA. Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant. 2008;14(3):356 -363
33. Chan KW, Gajewski JL, Supkis D Jr, Pentz R, Champlin R, Bleyer WA. Use of minors as bone marrow donors: current attitude and management-a survey of 56 pediatric transplantation centers. J Pediatr. 1996; 128(5 pt 1):644-648
34. Kennedy GA, Morton J, Western R, Butler J, Daly J, Durrant S. Impact of stem cell donation modality on normal donor quality of life: a prospective randomized study. Bone Marrow Transplantation. 2003;31(11): 1033-1103
35. Bone marrow transplantation from unrelated volunteer donors: summary of a conference on scientific, ethical, legal, financial, and other practical issues. Transfusion. 1982;22(1):78-81
36. Pulsipher MA, Nagler A, Iannone R, Nelson RM. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer. 2006; 46(4):422-433
37. Confer DL. Hematopoietic cell donors. In: Blume KG, Forman SJ, Appelbaum F, eds. Thomas' Hematopoietic Cell Transplantation. MA: Blackwell; 2004:538-549Vol 1. Malden
38. Sanders J, Buckner CD, Bensinger WI, Levy W, Chard R, Thomas ED. Experience with marrow harvesting from donors less than two years of age. Bone Marrow Transplant. 1987;2(1):45-50
39. Pulsipher MA, Levine JE, Hayashi RJ, et al. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: the pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003. Bone Marrow Transplant. 2005;35(4): 361-367
40. Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant. 2001; 27(7):689-692
41. Department of Health and Human Services. 45 CFR part 46, Subpart D. Protections for children involved as subjects in research. Fed Regist. 1983;48:9814 -9820;
42. revised Fed Regist. 1991;56(46):28032
43. Runyan CW, Zakocs RC. Epidemiology and prevention of injuries among adolescent workers in the United States. Annu Rev Public Health. 2000;21:247-269
44. Ross LF. Children in Research: Access Versus Protection. Oxford, United Kingdom: Oxford University Press; 2006
45. Spinks AB, McClure RJ. Quantifying the risk of sports injury: a systematic review of activity-specific rates for children under 16 years of age. Br J Sports Med. 2007; 41(9):548-557
46. Ross LF. Children, Families and Health Care Decision Making. Oxford, United Kingdom: Oxford University Press; 1998
47. Nelson HL, Nelson JL. The Patient in the Family: An Ethics of Medicine and Families. New York, NY: Routledge; 1995
48. Hardwig J, ed. Is There a Duty to Die? And Other Essays in Bioethics. New York, NY: Routledge; 2000
49. Dwyer J, Vig E. Rethinking transplantation between siblings. Hastings Cent Rep. 1995; 25(6):7-12
50. Anderlini P, Champlin RE. Biologic and molecular effects of granulocyte colonystimulating factor in healthy individuals: recent findings and current challenges. Blood. 2008;111(4):1767-1772
51. Tigue CC, McKoy JM, Evens AM, Trifilio SM, Tallman MS, Bennett CL. Granulocytecolony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. 2007;40(3):185-192
52. Pulsipher MA, Chitphakdithai P, Miller JP, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113(15):3604- 3611
53. Moise KJ Jr. Umbilical cord stem cells. Obstet Gynecol. 2005;106(6):1393-1407
54. Institute of Medicine. Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program. Washington, DC: National Academies Press; 2005. Available at: www. iom.edu/CMS/3740/20073/26386.aspx. Accessed November 20, 2009
55. Krishnamurti L, Abel S, Maiers M, Flesch S. Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies. Bone Marrow Transplant. 2003;31(7):547-550
56. Rocha V, Wagner JE Jr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000;342(25): 1846-1854
57. MacLeod KD, Whitsett SF, Mash EJ, Pelletier W. Pediatric sibling donors of successful and unsuccessful hematopoietic stem cell transplants (HSCT): a qualitative study of their psychosocial experience. J Pediatr Psychol. 2003;28(4):223-231
58. Weisz V, Robbennolt JK. Risks and benefits of pediatric bone marrow donation: a critical need for research. Behav Sci Law. 1996;14(4):375-391
59. Shama WI. The experience and preparation of pediatric sibling bone marrow donors. Soc Work Health Care. 1998;27(1): 89-99
60. Heiney SP, Bryant LH, Godder K, Michaels J. Preparing children to be bone marrow donors. Oncol Nurs Forum. 2002;29(10): 1485-1499
61. Wiener LS, Steffen-Smith E, Battles HB, Wayne A, Love CP, Fry T. Sibling stem cell donor experiences at a single institution. Psychooncology. 2008;17(3):304-307
62. Carr-Gregg M, White L. Siblings of paediatric cancer patients: a population at risk. Med Pediatr Oncol. 1987;15(2):62-68
63. Wiener LS, Steffen-Smith E, Fry T, Wayne AS. Hematopoietic stem cell donation in children: a review of the sibling donor experience. J Psychosoc Oncol. 2007;25(1): 45-66
64. Houtzager BA, Grootenhuis MA, Last BF. Adjustment of siblings to childhood cancer: a literature review. Support Care Cancer. 1999;7(5):302-320
65. Pot-Mees CC, Zeitlin H. Psychosocial consequences of bone marrow transplantation in children: a preliminary communication. J Psychosoc Oncol. 1987;5(2):73-81
66. Packman WL, Crittenden MR, Schaeffer E, Bongar B, Fischer JB, Cowan MJ. Psychosocial consequences of bone marrow transplantation in donor and nondonor siblings. J Dev Behav Pediatr. 1997;18(4): 244-253
67. Packman WL, Crittenden MR, Rieger Fischer JB, Schaeffer E, Bongar B, Cowan MJ. Siblings' perceptions of the bone marrow transplant process. J Psychosoc Oncol. 1998;15(3&4):81-105
68. Eapen M, Logan BR, Confer DL, et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant. 2007;13(12):1461-1468
69. Eapen M, Horowitz MM, Klein JP, et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol. 2004; 22(24):4872-4880
70. Levine MD, Camitta BM, Nathan D, Curran WJ. The medical ethics of bone marrow transplantation in childhood. J Pediatr. 1975;86(1):145-150
71. Moore J, Nivison-Smith I, Goh K, et al. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia. Biol Blood Marrow Transplant. 2007;13(5): 601-607
72. Gassas A, Sung L, Saunders EF, Doyle J. Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations. Bone Marrow Transplant. 2007;40(10):951-955
73. Eisner MD, August CS. Impact of donor and recipient characteristics on the development of acute and chronic graft-versushost disease following pediatric bone marrow transplantation. Bone Marrow Transplant. 1995;15(5):663-668
74. A life-saving sibling helps out once more. The New York Times. June 7, 1992. Available at: www.nytimes.com/1992/06/07/us/ a-life-saving- sibling-helps-out-oncemore. html. Accessed November 20, 2009
75. Hardesty G. The baby born to save her sister says she has no regrets. Available at: www.ocregister.com/articles/marissaanissa-ayala-2100465-marrow- story. Accessed November 20, 2009
76. Curran v Bosze, 566 NE 2d 1319 (Ill 1990)
77. Opel DJ, Diekema DS. The case of A.R.: the ethics of sibling donor bone marrow transplantation revisited. J Clin Ethics. 2006;17(3):207-219
78. Ross LF, Glannon W. A compounding of errors: the case of bone marrow donation between non-intimate siblings. J Clin Ethics. 2006;17(3):220-226
79. Kesselheim JC, Lehmann LE, Styron NF, Joffe S. Is blood thicker than water? Ethics of hematopoietic stem cell donation by biological siblings of adopted children. Arch Pediatr Adolesc Med. 2009;163(5):413-416
80. Ross LF. The ethics of hematopoietic stem cell donation by minors. Arch Pediatr Adolesc Med. 2009;163(11):1065; author reply 1065-1066
81. Butterworth VA, Simmons RG, Schimmel M. When altruism fails: reactions of unrelated bone marrow donors when the recipient dies. Omega. 1993;26(3):161-173
82. Delany L, Month S, Savulescu J, Browett P, Palmer S. Altruism by proxy: volunteering children for bone marrow donation. BMJ. 1996;312(7025):240- 243
83. American Academy of Pediatrics, Committee on Bioethics. Informed consent, parental permission, and assent in pediatric practice. Pediatrics. 1995;95(2):314-317
84. Department of Health and Human Services, Centers for Medicare and Medicaid Services. Medicare program; hospital conditions of participation: requirements for approval and re-approval of transplant centers to perform organ transplants. Final rule. Fed Regist. 2007;72(61):15197-15280
85. Ross LF, Thistlethwaite JR Jr; American Academy of Pediatrics, Committee on Bioethics. Minors as living solid-organ donors. Pediatrics. 2008;122(2):454-461
86. Pentz RD, Chan KW, Neumann JL, Champlin RE, Korbling M. Designing an ethical policy for bone marrow donation by minors and others lacking capacity. Camb Q Healthc Ethics. 2004;13(2):149-155
87. Zinner S. Cognitive development and pediatric consent to organ donation. Camb Q Healthc Ethics. 2004;13(2):125-132
88. Packman WL. Psychosocial impact of pediatric BMT on siblings. Bone Marrow Transplant. 1999;24(7):701-706
89. Wis Stat S. 146.34(4) (2005)
90. Wendler D, Belsky L, Thompson KM, Emanuel EJ. Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit. JAMA. 2005;294(7):826-832
91. Kopelman L. Moral problems in assessing research risk. IRB. 2000;22(5):3-6
92. Nelson RM, Ross LF. In defense of a single standard of research risk for all children. J Pediatr. 2005;147(5):565-566
93. Institute of Medicine, Committee on Clinical Research Involving Children. The Ethical Conduct of Clinical Research Involving Children. Field MJ, Behrman RE, eds. Washington, DC: National Academies Press; 2004
94. Kopelman LM. What conditions justify risky nontherapeutic or "no benefit" pediatric studies: a sliding scale analysis. J Law Med Ethics. 2004;32(4):749-758
95. Ross LF. The ethics of type 1 diabetes prediction and prevention research. Theor Med Bioeth. 2003;24(2):177-197
96. Fisher CB, Kornetsky SZ, Prentice ED. Determining risk in pediatric research with no prospect of direct benefit: time for a national consensus on the interpretation of federal regulations. Am J Bioeth. 2007; 7(3):5-10
97. Ross LF. Do healthy children deserve greater protection in medical research? J Pediatr. 2003;142(2):108-112
98. Pentz RD. Healthy sibling donation of G-CSF primed stem cells: a call for research. Pediatr Blood Cancer. 2006;46(4):407-408
99. Peerzada JM, Wendler D. Hematopoietic stem cell transplant research with pediatric donors: when can institutional review boards approve it? Transplantation. 2006; 81(12):1616-1620
100. Children's Oncology Group. Protocol ASCT0631: a phase III randomized trial of granulocyte colony stimulating factor (GCSF) stimulated bone marrow vs. conventional bone marrow as a stem cell source in matched sibling donor transplantation. Available at: www.hhs.gov/ohrp/children/ gcsf.html. Accessed November 20, 2009
101. Gordon B; National Cancer Institute, Pediatric Institutional Review Board. CIRB approval pending modification to initial review [letter]. Available at: www.fda.gov/ ohrms/dockets/ac/08/briefing/2008-4406b1- 14%20(ASCT0631%20Initial%20Review% 20APM%20Letter).pdf. Accessed November 20, 2009
102. Joffe S, Fernandez CV, Pentz RD, et al. Involving children with cancer in decisionmaking about research participation. J Pediatr. 2006;149(6):862-868
103. Kuliev A, Rechitsky S, Tur-Kaspa I, Verlinsky Y. Preimplantation genetics: improving access to stem cell therapy. Ann N Y Acad Sci. 2005;1054:223-227
104. Pennings G, Schots R, Liebaers I. Ethical considerations on preimplantation genetic diagnosis for HLA typing to match a future child as a donor of haematopoietic stem cells to a sibling. Hum Reprod. 2002; 17(3):534-538
105. Dickens BM. Preimplantation genetic diagnosis and "savior siblings." Int J Gynaecol Obstet. 2005;88(1):91-96
106. Devolder K. Preimplantation HLA typing: having children to save our loved ones. J Med Ethics. 2005;31(10):582-586
107. Spriggs M. Is conceiving a child to benefit another against the interests of the new child? J J Med Ethics. 2005;31(6):341-342; discussion 343
108. Wolf SM, Kahn JP, Wagner JE. Using preimplantation genetic diagnosis to create a stem cell donor: issues, guidelines and limits. J Law Med Ethics. 2003;31(3): 327-339
109. Kant I. Grounding for the Metaphysics of Morals (1785). Ellington J, translator. Indianapolis, IN: Hackett Publishing Co; 1981
110. Serota FT, August CS, O'Shea AT, Woodward WT Jr, Koch PA. Role of a child advocate in the selection of donors for pediatric bone marrow transplantation. J Pediatr. 1981; 98(5):847-850